Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

SR9009

Base Information Edit
SR9009

Synonyms:SR9009;3-[[[(4-Chlorophenyl)methyl][(5-nitro-2-thienyl)methyl]amino]methyl]-1-pyrrolidinecarboxylic acid ethyl ester

Suppliers and Price of SR9009
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • SR9009
  • 5mg
  • $ 70.00
  • TRC
  • SR9009
  • 25mg
  • $ 165.00
  • Tocris
  • SR9009 ≥98%(HPLC)
  • 50
  • $ 696.00
  • Tocris
  • SR9009 ≥98%(HPLC)
  • 10
  • $ 169.00
  • DC Chemicals
  • Stenabolic(SR9009) >98%
  • 100 mg
  • $ 200.00
  • DC Chemicals
  • Stenabolic(SR9009) >98%
  • 1 g
  • $ 800.00
  • Crysdot
  • SR9009 98+%
  • 50mg
  • $ 321.00
  • Crysdot
  • SR9009 98+%
  • 100mg
  • $ 529.00
  • Chemenu
  • ethyl3-(((4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino)methyl)pyrrolidine-1-carboxylate 98%
  • 100mg
  • $ 503.00
  • Cayman Chemical
  • SR9009 ≥98%
  • 10mg
  • $ 125.00
Total 131 raw suppliers
Chemical Property of SR9009 Edit
Chemical Property:
  • Boiling Point:547.2±45.0 °C(Predicted) 
  • PKA:6.12±0.50(Predicted) 
  • PSA:106.84000 
  • Density:1.327±0.06 g/cm3(Predicted) 
  • LogP:5.25140 
  • Storage Temp.:-20° 
  • Solubility.:Soluble in DMSO (greater than 25 mg/ml) or in Ethanol (up to 20 mg/ml). 
Purity/Quality:

99% *data from raw suppliers

SR9009 *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Description SR-9009 is an agonist at nuclear receptor Rev-ErbA. Greatly diminishes VILI-induced lung edema, inflammatory cell infiltration and TNFα production in a rat lung injury model. SR-9009 suppresses atherosclerosis in a mouse model. Specifically lethal to cancer cells and oncogene-induced senescent cells with no effect on the viability of normal cells or tissues. Disrupts pain associated with osteoarthritis by reducing BMAL1 expression in bmal1f/fNav1.8CreERT mice.
  • Uses SR 9009 is a synthetic REV-ERB agonist that regulates circadian behavior and metabolism; has potential use in the treatment of sleep disorders and metabolic diseases. It is a lead compound for a new class of cancer drugs associated with the body’s circadian clock.
Technology Process of SR9009

There total 5 articles about SR9009 which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
Multi-step reaction with 4 steps
1: sodium tris(acetoxy)borohydride; acetic acid / 1,2-dichloro-ethane
2: sodium tris(acetoxy)borohydride; acetic acid / 1,2-dichloro-ethane
3: trifluoroacetic acid / dichloromethane
4: triethylamine / dichloromethane
With sodium tris(acetoxy)borohydride; acetic acid; triethylamine; trifluoroacetic acid; In dichloromethane; 1,2-dichloro-ethane;
DOI:10.1016/j.bmcl.2012.04.126
Guidance literature:
Multi-step reaction with 3 steps
1: sodium tris(acetoxy)borohydride; acetic acid / 1,2-dichloro-ethane
2: trifluoroacetic acid / dichloromethane
3: triethylamine / dichloromethane
With sodium tris(acetoxy)borohydride; acetic acid; triethylamine; trifluoroacetic acid; In dichloromethane; 1,2-dichloro-ethane;
DOI:10.1016/j.bmcl.2012.04.126
Guidance literature:
Multi-step reaction with 2 steps
1: trifluoroacetic acid / dichloromethane
2: triethylamine / dichloromethane
With triethylamine; trifluoroacetic acid; In dichloromethane;
DOI:10.1016/j.bmcl.2012.04.126
Refernces Edit
Post RFQ for Price